About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 709145, 12 pages
http://dx.doi.org/10.1155/2013/709145
Research Article

Immunocytochemical Characterization of Alzheimer Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine

1Department of Neurosciences, EuroEspes Biotechnology, 15165 La Coruna, Spain
2Department of Human Sciences, Texas A&M University-Kingsville, Kingsville, TX, USA
3Atlas Pharmaceuticals, Sunnyvale, CA, USA
4National Institute on Aging, National Institutes of Health, Baltimore, MD, USA
5Medical Center of the Administration of the President of the Republic of Kazakhstan, Astana, Kazakhstan
6EuroEspes Biomedical Research Center, Institute for CNS Disorders and Genomic Medicine, 15165 La Coruna, Spain
7“GALLY” International Biomedical Research Consulting LLC, San Antonio, TX, USA
8Department of Health Science and Healthcare Administration, University of Atlanta, Atlanta, GA, USA

Received 10 April 2013; Revised 11 June 2013; Accepted 2 July 2013

Academic Editor: Aaron Dumont

Copyright © 2013 Iván Carrera et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Iván Carrera, Ignacio Etcheverría, Yi Li, et al., “Immunocytochemical Characterization of Alzheimer Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine,” BioMed Research International, vol. 2013, Article ID 709145, 12 pages, 2013. doi:10.1155/2013/709145